Prasco LLC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Prasco LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7535
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Prasco LLC (Prasco Laboratories) is a pharmaceutical company that manufactures and markets authorized generic and generic products. The company’s authorized generic products include acitretin capsules, clotrimazole and betamethasone dipropionate cream, atovaquone and proguanil HCl tablets, calcipotriene cream, and carbamazepine extended-release capsules. It also provides augmented betamethasone dipropionate, levalbuterol HCl inhalation solution, mirtazapine orally disintegrating tablets and mupirocin calcium cream, among others. Prasco Laboratories’ generic products comprise duloxetine delayed release capsules, olanzapine orally disintegrating tablets, raloxifene Hcl, pantoprazole sodium delayed-release tablets, and olanzapine tablets. The company partners with various pharmaceutical companies for manufacturing authorized generic products. It has operations in Cincinnati and Washington D.C., the US. Prasco Laboratories is headquartered in Mason, Ohio, the US.

Prasco LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Prasco LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Prasco LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Prasco LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Prasco LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Prasco LLC, Medical Devices Deals, 2012 to YTD 2018 9
Prasco LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Prasco LLC, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Prasco to Acquire Authorized Generic of Adderall XR Capsules from Teva Pharma and Shire 11
Partnerships 13
Prasco Lab Enters into Co-Marketing Agreement with Takeda Pharma 13
Prasco Labs Enters into Distribution Agreement with Recordati Rare Diseases 14
Prasco Labs Enters Into Distribution Agreement With Eli Lilly For Evista 15
Prasco Labs Enters Into Agreement With Shire For Distribution Of Fosrenol 16
Prasco Labs Enters Into Distribution Agreement With WellSpring Pharma For Phenoxybenzamine Hydrochloride Capsules 17
Prasco Labs Enters into Distribution Agreement with Sunovion Pharma for Xopenex 18
ViroPharma Enters Into Co-Marketing Agreement With Prasco Labs For Vancocin 19
Prasco Labs Enters Into Co-Marketing Agreement With Shire For Carbatrol 20
Asset Transactions 21
IGI Labs Acquires Econazole Nitrate Cream From Prasco 21
Acquisition 22
Prasco Laboratories Acquires Additional stake in Aprecia Pharma 22
Prasco LLC – Key Competitors 23
Prasco LLC – Key Employees 24
Prasco LLC – Locations And Subsidiaries 25
Head Office 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Prasco LLC, Pharmaceuticals & Healthcare, Key Facts 2
Prasco LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Prasco LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Prasco LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Prasco LLC, Deals By Therapy Area, 2012 to YTD 2018 8
Prasco LLC, Medical Devices Deals, 2012 to YTD 2018 9
Prasco LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Prasco to Acquire Authorized Generic of Adderall XR Capsules from Teva Pharma and Shire 11
Prasco Lab Enters into Co-Marketing Agreement with Takeda Pharma 13
Prasco Labs Enters into Distribution Agreement with Recordati Rare Diseases 14
Prasco Labs Enters Into Distribution Agreement With Eli Lilly For Evista 15
Prasco Labs Enters Into Agreement With Shire For Distribution Of Fosrenol 16
Prasco Labs Enters Into Distribution Agreement With WellSpring Pharma For Phenoxybenzamine Hydrochloride Capsules 17
Prasco Labs Enters into Distribution Agreement with Sunovion Pharma for Xopenex 18
ViroPharma Enters Into Co-Marketing Agreement With Prasco Labs For Vancocin 19
Prasco Labs Enters Into Co-Marketing Agreement With Shire For Carbatrol 20
IGI Labs Acquires Econazole Nitrate Cream From Prasco 21
Prasco Laboratories Acquires Additional stake in Aprecia Pharma 22
Prasco LLC, Key Competitors 23
Prasco LLC, Key Employees 24

List of Figures
Prasco LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Prasco LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Prasco LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Prasco LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Prasco LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Prasco LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Prasco LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Prasco LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Prasco LLC, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Prasco LLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Aston Martin Lagonda Global Holdings Plc (AML):企業の財務・戦略的SWOT分析
    Aston Martin Lagonda Global Holdings Plc (AML) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • Cardinal Ethanol LLC (CRDE):企業の戦略的SWOT分析
    Cardinal Ethanol LLC (CRDE) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • National Oilwell Varco Inc (NOV):石油・ガス:M&Aディール及び事業提携情報
    Summary National Oilwell Varco Inc (NOV) is a provider of technology, equipment, and services to the oil and gas industry. The company’s portfolio of offerings includes rig systems, wellbore technologies, and completion and production solutions. Its product line comprises fiber glass systems, floati …
  • Mitteldeutsche Braunkohlengesellschaft mbH:企業の戦略的SWOT分析
    Mitteldeutsche Braunkohlengesellschaft mbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors an …
  • China Food Company PLC :企業の戦略・SWOT・財務情報
    China Food Company PLC - Strategy, SWOT and Corporate Finance Report Summary China Food Company PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Huiyin Household App. (Hold.) Co., Ltd.:戦略・SWOT・企業財務分析
    Huiyin Household App. (Hold.) Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Huiyin Household App. (Hold.) Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Exelon Corporation:企業の戦略・SWOT・財務情報
    Exelon Corporation - Strategy, SWOT and Corporate Finance Report Summary Exelon Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Teco Energy Inc:企業の戦略的SWOT分析
    Teco Energy Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Regency Centers Corporation:企業のM&A・事業提携・投資動向
    Regency Centers Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Regency Centers Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Innovation Pharmaceuticals Inc (IPIX):製薬・医療:M&Aディール及び事業提携情報
    Summary Innovation Pharmaceuticals Inc (Innovation Pharmaceuticals), formerly Cellceutix Corp, is a biopharmaceutical company that discovers and advances medical therapies with dermatology, oncology, anti-inflammatory and antibiotic applications. The company provides pipeline products such as kevetr …
  • Norgine BV:企業の戦略的SWOT分析
    Norgine BV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • TerraForm Power Inc (TERP):電力:M&Aディール及び事業提携情報
    Summary TerraForm Power Inc (TerraForm Power), formerly SunEdison Yieldco Inc, a subsidiary of Brookfield Asset Management Inc, is an energy development company that owns and operates energy power plants. The company generates and distributes renewable energy by utilizing various clean power generat …
  • Cinemark Holdings Inc (CNK):企業の財務・戦略的SWOT分析
    Cinemark Holdings Inc (CNK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Nahar Industrial Enterprises Limited (NAHARINDUS):企業の財務・戦略的SWOT分析
    Nahar Industrial Enterprises Limited (NAHARINDUS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • CASI Pharmaceuticals Inc (CASI):製薬・医療:M&Aディール及び事業提携情報
    Summary CASI Pharmaceuticals Inc (CASI) is a biopharmaceutical company, which focuses on the acquisition, development and commercialization of innovative therapies for treating cancer and other unmet medical needs. Its pipeline product portfolio includes ENMD-2076 that is being developed globally fo …
  • American Axle & Manufacturing Holdings Inc (AXL):企業の財務・戦略的SWOT分析
    American Axle & Manufacturing Holdings Inc (AXL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key s …
  • Intertape Polymer Group Inc (ITP):企業の財務・戦略的SWOT分析
    Intertape Polymer Group Inc (ITP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Carbon Energy Corp (CRBO):石油・ガス:M&Aディール及び事業提携情報
    Summary Carbon Energy Corp (Carbon Energy), formerly Carbon Natural Gas Company is an independent oil and gas company. The company operates in the exploration, operation, management, and development of oil and gas properties in the Appalachian and Illinois Basin regions of the US. It holds interests …
  • Sembcorp Industries Ltd (U96):石油・ガス:M&Aディール及び事業提携情報
    Summary Sembcorp Industries Ltd (Sembcorp) is a diversified energy, water and marine company. It provides solutions across the energy and utilities value chain, with a focus on gas and power, renewables and environment, and merchant and retail sectors. The company carries out production and supply o …
  • Asklepios BioPharmaceutical Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Asklepios Biopharmaceutical Inc (Asklepios Biopharmaceutical) is a drug development company that develops and markets novel protein and cellular based therapies. The company’s products include BNP-CHF, biostrophin, AskBio009, BNP-FVIII, BNP-RP, BNP-TLE, and BNP-OA. It also provides products …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆